Skip to main content
High RiskFDAfda-F-1687-2014CHOKING

Stage 2 World Baby Thailand; Roasted Pumpkin & Coconut Rice, 3.5 oz. pouch. Product of USA distributed by Plum Inc., Emeryville, CA

Units Affected
11,595
Recall Date
March 4, 2014
Issuing Agency
Hazard
Choking

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1687-2014.

Intermittent damage to the plastic spouts during manufacturing of two varieties of Plum products on two production dates may cause plastic fragments to break loose and cause a potential choking hazard.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1687-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Plum Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1687-2014.

Plum Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Plum Inc Recall FAQ

Plum Inc is the subject of a baby food & formula safety report: Stage 2 World Baby Thailand; Roasted Pumpkin & Coconut Rice, 3.5 oz. pouch. Product of USA distributed by Plum Inc., Emeryville, CA. The notice was published on March 4, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 11,595 units are potentially affected.